Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perou

Showing results (451-460 of 476) with videos related to

Pageof 48
Sort By:
Nature Genetics|September 8, 2021
A single-cell and spatially resolved atlas of human breast cancersSunny Z Wu, Ghamdan Al-Eryani, Daniel Lee Roden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerG Villacampa, N M Tung, S Pernas, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.
Science (New York, N.Y.)|April 23, 2021
Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accidentLindsay M Morton, Danielle M Karyadi, Chip Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Nature Communications|March 29, 2017
Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
The Journal of Pathology|March 29, 2024
Research autopsy programmes in oncology: shared experience from 14 centres across the worldTatjana Geukens, Marion Maetens, Jody E Hooper, et al.
Pageof 48

Showing results (451-460 of 476) with videos related to

Sort By:
Pageof 48
Nature Genetics|September 8, 2021
A single-cell and spatially resolved atlas of human breast cancersSunny Z Wu, Ghamdan Al-Eryani, Daniel Lee Roden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2023
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerG Villacampa, N M Tung, S Pernas, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
British Journal of Cancer|August 8, 2014
Predicting response and survival in chemotherapy-treated triple-negative breast cancerA Prat, A Lluch, J Albanell, et al.
Science (New York, N.Y.)|April 23, 2021
Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accidentLindsay M Morton, Danielle M Karyadi, Chip Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 17, 2024
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyM Martín, S R Stecklein, O Gluz, et al.
Nature Communications|March 29, 2017
Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
The Journal of Pathology|March 29, 2024
Research autopsy programmes in oncology: shared experience from 14 centres across the worldTatjana Geukens, Marion Maetens, Jody E Hooper, et al.
Pageof 48